Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The RMR Group Inc. Announces Fourth Quarter Fiscal 2024 Results
-
NYSE Group Consolidated Short Interest Report
-
Orion S.A. to Participate in Baird’s Global Industrial Conference
-
Trane Technologies Champions Decarbonization, Sustainable Cooling and Climate Policies at COP29
-
Precision Optics Corporation Schedules First Quarter of Fiscal Year 2025 Conference Call for November 14, 2024
-
Gatos Silver Reports Third Quarter 2024 Results Including a 200% Increase in Earnings Per Share
-
Aterian Reports Third Quarter 2024 Results
-
LICT Corporation Reports Results for the 3rd Quarter 2024
-
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024
-
Angi Inc. Earnings Release Available on Company's Website
-
IAC Earnings Release and Letter to Shareholders Available on Company's Website
-
Beneficient Announces Second Quarter Fiscal 2025 Earnings Release and Webcast
-
LSB Industries, Inc. Appoints John Chandler as an Independent Member of the Board of Directors
-
James River Announces Third Quarter 2024 Results, Strategic Actions
-
Angi Inc. Earnings Release Available on Company's Website
-
Okeanis Eco Tankers Corp. – 2023 ESG Report
-
Endeavor Announces Management Buyout of OpenBet and IMG ARENA
-
Four Standout Housing Leadership Webinars
-
Live Nation Entertainment Reports Third Quarter 2024 Results
-
The Prelude Network Honors Military Families Month by Expanding Access to Fertility Care to Veterans and Active-Duty Service Members
-
Assured Guaranty Ltd. Reports Results for Third Quarter 2024
-
Galway Metals Announces Closing Of Private Placement Of Flowthrough Units
-
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
-
Bridger Aerospace Announces Record Third Quarter 2024 Results; Raises Revenue Guidance and Narrows Adjusted EBITDA Estimates
-
Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update
-
Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for SPY001, its Novel Half-Life Extended Anti-α4β7 Antibody for the Treatment fo
-
MARPAI REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
-
Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease
-
QuickLogic Reports Financial Results for its Fiscal Third Quarter 2024
-
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
-
IO Biotech Announces Participation in Upcoming Investor Conferences
-
Local Bounti to Release Third Quarter 2024 Financial Results on Thursday, November 14, 2024
-
Nevro Reports Third-Quarter 2024 Financial Results
-
Zeta Accelerates Revenue Growth to 42% and Achieves the “Rule of 60” in 3Q’24
-
Bond Vet Unleashes AI-Driven Data Technology with Domo to Stay Ahead of the Pack
-
Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update
-
Intevac Announces Third Quarter 2024 Financial Results
-
Zillow Group to present at RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference
-
Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting
-
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
-
Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering
-
Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024
-
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024
-
Bitfarms Reschedules Third Quarter 2024 Conference Call to November 13th, 2024
-
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
-
Nature’s Sunshine Appoints Steven Fasching to Board of Directors
-
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2024
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CSX Executive Vice President and Chief Commercial Officer to Address Stephens Annual Investment Conference

